MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, VRTX made $12,001,300K in revenue. $3,953,200K in net income. Net profit margin of 32.94%.

Income Overview

Revenue
$12,001,300K
Net Income
$3,953,200K
Net Profit Margin
32.94%
EPS
$15.32
Unit: Thousand (K) dollars
Revenue Breakdown
    • TRIKAFTAKAFTRIO
    • ALYFTREK
    • Manufactured Product Other
    • Collaborativeand Royalty
Revenue Breakdown
    • US
    • Europe
    • Other Countries Outsideofthe Uni...

Income Statement
2025-12-31
2024-12-31
2023-12-31
2022-12-31
Product revenues, net
12,001,300 11,020,100 9,869,200 8,930,700
Cost of sales
1,651,300 1,530,500 1,262,200 1,080,300
Research and development expenses
3,909,500 3,630,300 3,162,900 2,540,300
Acquired in-process research and development expenses
133,000 4,628,400 527,100 115,500
Selling, general and administrative expenses
1,753,100 1,464,300 1,136,600 944,700
Intangible asset impairment charge
379,000 ---
Change in fair value of contingent consideration
2,100 -500 -51,600 -57,500
Total costs and expenses
7,828,000 11,253,000 6,037,200 4,623,300
Income (loss) from operations
4,173,300 -232,900 3,832,000 4,307,400
Interest income
490,900 598,100 614,700 144,600
Interest expense
13,300 30,600 -44,100 -54,800
Other expense, net
-7,700 -86,100 -22,800 -164,800
Income before provision for income taxes
4,643,200 248,500 4,379,800 4,232,400
Provision for income taxes
690,000 784,100 760,200 910,400
Income (loss)
3,953,200 -535,600 3,619,600 3,322,000
Basic EPS
15.46 -2.08 14.05 12.97
Diluted EPS
15.32 -2.08 13.89 12.82
Basic Average Shares
255,700,000 257,900,000 257,700,000 256,100,000
Diluted Average Shares
258,000,000 257,900,000 260,500,000 259,100,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
TRIKAFTAKAFTRIO$10,312,700K (0.72%↑ Y/Y)ALYFTREK$837,800K Manufactured Product Other$820,100K (4.94%↑ Y/Y)Product$11,970,600K Collaborativeand Royalty$30,700K Product revenues, net$12,001,300K (8.90%↑ Y/Y)Income (loss) fromoperations$4,173,300K (1891.88%↑ Y/Y)Interest income$490,900K (-17.92%↓ Y/Y)Total costs andexpenses$7,828,000K (-30.44%↓ Y/Y)Income beforeprovision for income taxes$4,643,200K (1768.49%↑ Y/Y)Interest expense$13,300K (-56.54%↓ Y/Y)Other expense, net-$7,700K (91.06%↑ Y/Y)Research and developmentexpenses$3,909,500K (7.69%↑ Y/Y)Selling, general andadministrative expenses$1,753,100K (19.72%↑ Y/Y)Cost of sales$1,651,300K (7.89%↑ Y/Y)Intangible assetimpairment charge$379,000K Acquired in-processresearch and development...$133,000K (-97.13%↓ Y/Y)Change in fair value ofcontingent consideration$2,100K (520.00%↑ Y/Y)Income (loss)$3,953,200K (838.09%↑ Y/Y)Provision for income taxes$690,000K (-12.00%↓ Y/Y)

logo-vertex-inc-svg copy-svg

VERTEX PHARMACEUTICALS INC MA (VRTX)

logo-vertex-inc-svg copy-svg

VERTEX PHARMACEUTICALS INC MA (VRTX)